Side-by-side financials for ABVC and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABVC | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $509.59K | - |
| Net income (latest FY) | -$7.91M | - |
| Net margin | -1551.9% | - |
| SEC filings | 780 | 1,004 |
Full pages: ABVC BIOPHARMA, INC. and AstraZeneca PLC, or browse the full rankings.